dapagliflozin
astrazeneca
['dapagliflozin', 'heart failure']
#esccongress | #deliver: among patients with #hfmref and #hfpef dapagliflozin resulted in a lower risk of the primary composite outcome of cv death or worsening heart failure reduced total heart failure hospitalizations and symptoms of heart failure, and improved symptom burden. 
Latest research in cardiology | Breaking news, insights, interviews, live tweeting and updates from major conferences. Co-published by @ilpensiero | @think2it